Bile acid-induced necrosis in primary human hepatocytes and in patients with obstructive cholestasis.

[1]  William M. Lee,et al.  Glycodeoxycholic acid levels as prognostic biomarker in acetaminophen-induced acute liver failure patients. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.

[2]  H. Jaeschke,et al.  Biomarkers distinguish apoptotic and necrotic cell death during hepatic ischemia/reperfusion injury in mice , 2014, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[3]  Mitchell R. McGill,et al.  Mechanisms of acetaminophen-induced cell death in primary human hepatocytes. , 2014, Toxicology and applied pharmacology.

[4]  H. Jaeschke,et al.  Lithocholic acid feeding results in direct hepato-toxicity independent of neutrophil function in mice. , 2014, Toxicology letters.

[5]  Mitchell R. McGill,et al.  Neutrophil activation during acetaminophen hepatotoxicity and repair in mice and humans. , 2014, Toxicology and applied pharmacology.

[6]  Hartmut Jaeschke,et al.  Osteopontin is an initial mediator of inflammation and liver injury during obstructive cholestasis after bile duct ligation in mice. , 2014, Toxicology letters.

[7]  Hartmut Jaeschke,et al.  Plasma biomarkers of liver injury and inflammation demonstrate a lack of apoptosis during obstructive cholestasis in mice. , 2013, Toxicology and applied pharmacology.

[8]  Alasdair J Gray,et al.  Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital , 2013, Hepatology.

[9]  G. Gores,et al.  Apoptosis and necrosis in the liver. , 2013, Comprehensive Physiology.

[10]  K. Jemnitz,et al.  Comparison of Human Hepatoma HepaRG Cells with Human and Rat Hepatocytes in Uptake Transport Assays in Order to Predict a Risk of Drug Induced Hepatotoxicity , 2013, PloS one.

[11]  Hartmut Jaeschke,et al.  Novel insight into mechanisms of cholestatic liver injury. , 2012, World journal of gastroenterology.

[12]  U. Beuers,et al.  Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health. , 2012, Journal of hepatology.

[13]  Mitchell R. McGill,et al.  Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity. , 2012, Journal of hepatology.

[14]  Hartmut Jaeschke,et al.  The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation. , 2012, The Journal of clinical investigation.

[15]  Patrick Caron,et al.  Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study. , 2012, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[16]  H. Jaeschke,et al.  Effect of bile duct ligation on bile acid composition in mouse serum and liver , 2012, Liver international : official journal of the International Association for the Study of the Liver.

[17]  Hartmut Jaeschke,et al.  Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity , 2012, Liver international : official journal of the International Association for the Study of the Liver.

[18]  A. Hofmann.  Faculty Opinions recommendation of The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor κ light-chain enhancer of activated B cells (NF-κB) in mice. , 2011 .

[19]  B. M. Forman,et al.  The G‐Protein‐coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor kappa light‐chain enhancer of activated B cells (NF‐κB) in mice , 2011, Hepatology.

[20]  R. Straka,et al.  Profiling Circulating and Urinary Bile Acids in Patients with Biliary Obstruction before and after Biliary Stenting , 2011, PloS one.

[21]  Jason P. Zlotnicki,et al.  High Mobility Group Box 1 Release from Hepatocytes during Ischemia and Reperfusion Injury Is Mediated by Decreased Histone Deacetylase Activity* , 2010, The Journal of Biological Chemistry.

[22]  G. Gores,et al.  Hepatocyte death: a clear and present danger. , 2010, Physiological reviews.

[23]  H. Jaeschke,et al.  Oxidative Stress and the Pathogenesis of Cholestasis , 2010, Seminars in liver disease.

[24]  Dominic P. Williams,et al.  High-mobility group box-1 protein and keratin-18, circulating serum proteins informative of acetaminophen-induced necrosis and apoptosis in vivo. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[25]  M. Manns,et al.  The BH3-only protein bid does not mediate death-receptor-induced liver injury in obstructive cholestasis. , 2009, The American journal of pathology.

[26]  U. Beuers,et al.  Bile Acid-induced Apoptosis in Hepatocytes Is Caspase-6-dependent* , 2009, Journal of Biological Chemistry.

[27]  D. Häussinger,et al.  Expression and function of the bile acid receptor TGR5 in Kupffer cells. , 2008, Biochemical and biophysical research communications.

[28]  M. Trauner,et al.  Mechanisms of cholestasis. , 2008, Clinics in liver disease.

[29]  F. Tacke,et al.  Elevated apoptosis-associated cytokeratin 18 fragments (CK18Asp386) in serum of patients with chronic liver diseases indicate hepatic and biliary inflammation. , 2007, Clinical biochemistry.

[30]  D. Häussinger,et al.  The G‐protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells , 2007, Hepatology.

[31]  A. Befeler,et al.  High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis , 2007, Current gastroenterology reports.

[32]  Olivier Fardel,et al.  Differential Regulation of Sinusoidal and Canalicular Hepatic Drug Transporter Expression by Xenobiotics Activating Drug-Sensing Receptors in Primary Human Hepatocytes , 2006, Drug Metabolism and Disposition.

[33]  G. Gores,et al.  Apoptosis: a mechanism of acute and chronic liver injury , 2005, Gut.

[34]  K. Zatloukal,et al.  Oncosis represents the main type of cell death in mouse models of cholestasis. , 2005, Journal of hepatology.

[35]  H. Jaeschke,et al.  Reduced oncotic necrosis in fas receptor‐deficient C57BL/6J‐lpr mice after bile duct ligation , 2004, Hepatology.

[36]  H. Jaeschke,et al.  Acetaminophen-induced oxidant stress and cell injury in cultured mouse hepatocytes: protection by N-acetyl cysteine. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[37]  H. Jaeschke,et al.  Functional importance of ICAM-1 in the mechanism of neutrophil-induced liver injury in bile duct-ligated mice. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[38]  Tiziana Bonaldi,et al.  Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion , 2003, The EMBO journal.

[39]  H. Jaeschke,et al.  Neutrophils aggravate acute liver injury during obstructive cholestasis in bile duct–ligated mice , 2003, Hepatology.

[40]  H. Jaeschke,et al.  Oncotic necrosis and caspase-dependent apoptosis during galactosamine-induced liver injury in rats. , 2003, Toxicology and applied pharmacology.

[41]  F. Lammert,et al.  Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles. , 2002, Gastroenterology.

[42]  G. Gores,et al.  Mechanisms of hepatotoxicity. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[43]  P. Meier,et al.  Cholestatic expression pattern of sinusoidal and canalicular organic anion transport systems in primary cultured rat hepatocytes , 2001, Hepatology.

[44]  H. Jaeschke,et al.  Activation of caspase 3 (CPP32)-like proteases is essential for TNF-alpha-induced hepatic parenchymal cell apoptosis and neutrophil-mediated necrosis in a murine endotoxin shock model. , 1998, Journal of immunology.

[45]  J. Boyer,et al.  Expression of the rat liver Na+/taurocholate cotransporter is regulated in vivo by retention of biliary constituents but not their depletion , 1997, Hepatology.

[46]  P. Meier,et al.  Parallel decrease of Na+ ‐taurocholate cotransport and its encoding mRNA in primary cultures of rat hepatocytes , 1993, Hepatology.

[47]  G. Gores,et al.  Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes. Role of ATP depletion and cytosolic free calcium. , 1993, The Journal of clinical investigation.

[48]  P. Galle,et al.  Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes , 1990, Hepatology.

[49]  L. Barbara,et al.  Quantitative aspects of the interaction of bile acids with human serum albumin. , 1982, Journal of lipid research.

[50]  H. Jaeschke,et al.  Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis. , 2011, The American journal of pathology.

[51]  G. Gores,et al.  Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. , 1999, The Journal of clinical investigation.

[52]  J. Boyer,et al.  Down-regulation of expression and function of the rat liver Na+/bile acid cotransporter in extrahepatic cholestasis. , 1996, Gastroenterology.